Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

The treatment paradigm for the management of patients with advanced cancer…

Expiration Date: 7/7/2020

Max Credits: 1

View Activity

Oncology Consults: The Latest on the Biosimilar Revolution

Oncology Consults: The Latest on the Biosimilar Revolution

Several of the most-used cancer drugs are biologics and many, including ri…

Expiration Date: 6/27/2020

Max Credits: 0.75

View Activity

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 2.5

View Activity

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

Multigene assays that evaluate an array of prognostic and/or predictive mo…

Expiration Date: 6/10/2020

Max Credits: 1

View Activity

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly dia…

Expiration Date: 6/10/2020

Max Credits: 1

View Activity

Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Updates in Hepatocellular Carcinoma: Clinical Decision-making Among an Array of New Options

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide a…

Expiration Date: 5/23/2020

Max Credits: 0.75

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0.75

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 1

View Activity

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

Updates in Hematologic Malignancies: What You Might Have Missed in San Diego

Therapeutic options continue to expand for patients with hematologic malig…

Expiration Date: 2/13/2020

Max Credits: 0.75

View Activity

Optimizing Multiple Myeloma Treatment Selection in Your Community Oncology Practice

Optimizing Multiple Myeloma Treatment Selection in Your Community Oncology Practice

The approval and integration of several novel therapeutic agents into the …

Expiration Date: 1/6/2020

Max Credits: 0.75

View Activity